The present invention relates to a biomarker and method for identifying {HEAD ~ the subgroup} of {TAIL ~ early stage lung adenocarcinoma patients} in early stage NSCLC, which is helpful for the design of clinical trials for adjuvant therapy 
of
The present invention relates to a biomarker and method for identifying { HEAD ~ the subgroup } of { TAIL ~ early stage lung adenocarcinoma patients } in early stage NSCLC , which is helpful for the design of clinical trials for adjuvant therapy
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH